Citations

Clear

6273 citation(s) found for "To, Andrew".

A new C-peptide minimal model to assess β-cell responsiveness to glucagon in individuals with and without type 2 diabetes
Boscolo, Francesca S. , Faggionato, Edoardo , Welch, Andrew A. , FARAHANI, RAHELE A., Egan, Aoife M. , Vella, Adrian , Man, Chiara Dalla , Boscolo, Federica , Dalla Man, Chiara , Vella, Adrian , Egan, A M

Mayo Clinic

American Journal of Physiology-Endocrinology and Metabolism | February 10, 2025 | Volume: 328 | Issue: 3 | Pages: E470-E477

10.1152/ajpendo.00424.2024 | PMID 39925097 Get It

In this study, we propose a new mathematical model able to quantify C-peptide secretion and β-cell responsivity in response to a glucagon bolus in individuals without and with type 2 diabetes. We show that individuals with type 2 diabetes exhibit reduced β-cell responsivity to glucagon.
A Multicenter Comparison of CRH versus DDAVP Stimulation Responses in Inferior Petrosal Sinus Sampling for Cushing’s Disease
Karsy, Michael, Silverstein, Julie , Evans, James J., Collopy, Sarah , Kelly, Dan, Fernandez‐Miranda, Juan C. , Pacione, Donato , Bergsneider, Marvin , Zada, Gabriel , Kshettry, Varun R. , Wu, Kyle C., Benjamin, Carolina , Catalino, Michael P. , Zwagerman, Nathan T. , Little, Andrew S. , Yuen, Kevin Choong Ji, ITorok, Ildiko, Gardner, Paul A. , Karsy, Michael , Karsy, Michael , Kim, Albert Sungsoo , Rennert, Robert C , Couldwell, William T. , Barkhoudarian, Garni , Kim, Won Bae , Chicoine, Michael , Gompel, Jamie J. Van , Mamelak, Adam N. , Yuen, Kevin C.J.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 7, 2025 | Volume: 86 | Issue: No issue available | Pages: No page available

10.1055/s-0045-1803037 Get It

Simvastatin and Rifaximin in Decompensated Cirrhosis
Pose, Elisa , Jiménez, César , Zaccherini, Giacomo , Campion, Daniela , Wit, Koos de , Gananandan, Kohilan , Laleman, Wim , López, Sonia Alonso , Cuyàs, Berta , Ariza, Xavier , T., Ann , Napoleone, Laura , Gratacós‐Ginès, Jordi , Tonon, Marta , Pompili, Enrico , Sánchez‐Delgado, Jordi , Allegretti, Andrew S. , Carol, Marta, Pich, Judit, Martell, Claudia, Joyera, María, Domènech, Gemma, Ríos, José , Torres, Ferràn , Serra‐Burriel, Miquel , Graupera, Isabel , Bañares, Rafael, Beuers, Ulrich , Angeli, Paolo, Alessandria, Carlo , Kamath, Patrick S. , Vargas, Vı́ctor , Ma, Ann T , de Wit, Koos , Vargas, Victor , Jiménez, César , Cuyas, Berta , Torres, Ferran , Piano, Salvatore , Uschner, Frank Erhard , Roux, Olivier , Solé, Cristina , Juanola, Adrià , Morales‐Ruiz, Manuel , Pérez, Martina , Fabrellas, Núria , Joyera, Maria, Hernaez, Ruben , Solà, Elsa , Watson, Hugh R , Soriano, German , Bañares, Rafael , Mookerjee, Rajeshwar P. , Francoz, Claire , Trebicka, Jonel , Angeli, Paolo , Caraceni, Paolo , Vargas, Víctor M., Abraldeṣ, Juan G. , Ginès, Pere

Mayo Clinic

JAMA | February 5, 2025 | Volume: 333 | Issue: 10 | Pages: 864

10.1001/jama.2024.27441 | PMID 39908052 Get It

ImportanceThere are no useful treatments to prevent the development of severe complications of liver cirrhosis. Simvastatin and rifaximin have shown beneficial effects in liver cirrhosis.ObjectiveTo assess whether simvastatin combined with rifaximin improves outcomes in patients with decompensated cirrhosis.Design, Setting, and ParticipantsDouble-blind, placebo-controlled, phase 3 trial conducted among patients with decompensated cirrhosis in 14 European hospitals between January 2019 and December 2022. The last date of follow-up was December 2022.InterventionsPatients were randomly assigned to receive simvastatin, 20 mg/d, plus rifaximin, 1200 mg/d (n = 117), or identical-appearing placebo (n = 120) for 12 months in addition to standard therapy, stratified according to Child-Pugh class B or C.Main Outcomes and MeasuresThe primary end point was incidence of severe complications of liver cirrhosis associated with organ failure meeting criteria for acute-on-chronic liver failure. Secondary outcomes included transplant or death and a composite end point of complications of cirrhosis (ascites, hepatic encephalopathy, variceal bleeding, acute kidney injury, and infection).ResultsAmong the 237 participants randomized (Child-Pugh class B: n = 194; Child-Pugh class C: n = 43), 72% were male and the mean age was 57 years. There were no differences between the 2 groups in terms of development of acute-on-chronic liver failure (21 [17.9%] vs 17 [14.2%] patients in the treatment and placebo groups, respectively; hazard ratio, 1.23; 95% CI, 0.65-2.34; P = .52); transplant or death (22 [18.8%] vs 29 [24.2%] patients in the treatment and placebo groups, respectively; hazard ratio, 0.75; 95% CI, 0.43-1.32; P = .32); or development of complications of cirrhosis (50 [42.7%] vs 55 [45.8%] patients in the treatment and placebo groups, respectively; hazard ratio, 0.93; 95% CI, 0.63-1.36; P = .70). Incidence of adverse events was similar in both groups (426 vs 419; P = .59), but 3 patients in the treatment group (2.6%) developed rhabdomyolysis.Conclusions and RelevanceThe addition of simvastatin plus rifaximin to standard therapy does not improve outcomes in patients with decompensated liver cirrhosis.Trial RegistrationClinicalTrials.gov Identifier: NCT03780673
Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion
Goyal, Mayank , Möhlenbruch, Markus , Nimjee, Shahid M. , Buck, Brian , Kennedy, James , Zhang, Liqun , Hametner, Christian , Nardai, Sándor , Zafar, Atif , Diprose, William K. , Vatanpour, Shabnam , Stebner, Alexander, Bosshart, Salome , Uchida, Kazutaka , Ryckborst, Karla J., Fahed, Robert, Hu, Sherry , Zaidi, Syed , Lee, Vivien , Teal, Rachel, Trivedi, Anurag , Ogungbemi, Ayokunle, Orosz, Péter , Abdalkader, Mohamad , Taschner, Christian , Tarpley, Jason , Poli, Sven , Sahlas, Demetrios J. , Burns, Paul , Marigold, Richard , Amole, Adewumi, Field, Thalia S. , Settecase, Fabio , Lenzsér, Gábor, Asdaghi, Negar , Lobotesis, Kyriakos , Siddiqui, Adnan H. , Berrouschot, J., Ebersole, Koji , Schneider, Hauke , Mandzia, Jennifer, Klostranec, Jesse , Jadun, Changez, Patankar, Tufail , Sauvageau, Eric , Lenthall, Robert , Peeling, Lissa, Budzik, Ronald F. , Lee, Seon-Kyu, Perry, Richard , Hlaing, Thant , Singh, Paul, Hill, Michael D. , Vakharia, Kunal , Harston, George , Möhlenbruch, Markus A , Nimjee, Shahid M , Buck, Brian H , Kennedy, James , Zhang, Liqun , Hametner, Christian , Diprose, William , Vatanpour, Shabnam , Stebner, Alexander , Bosshart, Salome , Singh, Nishita , Hu, Sherry X , Vollherbst, Dominik F , Lee, Vivien H , Rempel, Jeremy L , Teal, Rachel , Trivedi, Anurag , Bode, Felix J , Abdalkader, Mohamad , Poli, Sven , Singh, Ravinder-Jeet , Lopez, George , Schaafsma, Joanna D , Marigold, Richard , Field, Thalia S , Settecase, Fabio , Ortega-Gutierrez, Santiago , Mokin, Maxim , Ebersole, Koji , Schneider, Hauke , Yoo, Albert J , Klostranec, Jesse , Lenthall, Robert , Huynh, Thien , Budzik, Ronald , Levitt, Michael R , Jahromi, Babak S , Hill, Michael D , Siddiqui, Adnan H , Ospel, Johanna M. , Ganesh, Aravind , Dowlatshahi, Dar , Volders, David , Jumaa, Mouhammad , Booth, Thomas Calvert , Shankar, Jai , Dorn, Franziska , Sebastian, Ivy Anne , Fahed, Robert , Lynch, Jeremy , Bode, Felix J. , Pham, Mirko , Leacy, Reade De , Chen, Michael , Reich, Arno , Swartz, Richard H. , Yoo, Albert J. , Huynh, Thien , Makalanda, Levansri , Levitt, Michael R. , Jahromi, Babak S. , Demchuk, Andrew M.

Mayo Clinic

New England Journal of Medicine | February 5, 2025 | Volume: 392 | Issue: 14 | Pages: 1385-1395

10.1056/nejmoa2411668 | PMID 39908448 Get It

Risks and Benefits of Caprini Score Recommended Thromboprophylaxis After Radical Prostatectomy and Nephrectomy
Klose, Charles , Rodgers, Ingrid L., Qualkenbush, Eric , Zganjar, Andrew , Brennan, Emily , Spaulding, Aaron , Thiel, David D. , Gibbs, Evan, Edwards, Michael A. , Brennan, Emily , Thiel, David, Spaulding, Aaron , Edwards, Michael

Mayo Clinic

Urology Practice | February 4, 2025 | Volume: 12 | Issue: 3 | Pages: 343-355

10.1097/upj.0000000000000781 | PMID 39903837 Get It

Developing innovative teaching strategies for pain medicine rotations tailored to Generation Z
Banik, Ratan K. , Sandozi, Heba , Bhullar, Sona, Wang, Eric J. , Chai, Thomas , Cheng, Jianguo , Hagedorn, Jonathan M. , Wahezi, Sayed , Kohan, Lynn , Akhtaruzzaman, AKM , Ibrahim, Mohab , Mendelson, Andrew , Hussain, Nasir , Wang, Eric , Hagedorn, Jonathan M , Kohan, Lynn R , Mendelson, Andrew M , Hussain, Nasir , Banik, Ratan K , Bhullar, Sona, Shaparin, Naum , Singh, Ambrish

Mayo Clinic

Regional Anesthesia & Pain Medicine | February 3, 2025 | Volume: No volume available | Issue: No issue available | Pages: rapm-2024-106297

10.1136/rapm-2024-106297 | PMID 39900453 Get It

Waist Circumference, a Body Shape Index, and Molecular Subtypes of Colorectal Cancer: A Pooled Analysis of Four Cohort Studies
Chalitsios, Christos V. , Markozannes, Georgios , Papagiannopoulos, Christos , Aglago, Elom K. , Berndt, Sonja I. , Buchanan, Daniel D. , Campbell, Peter T. , Chan, Andrew T. , Dimou, Niki , Drew, David A. , French, Amy J. , Georgeson, Peter , Giannakis, Marios , Gruber, Stephen B. , Harrison, Tabitha A. , Hullar, Meredith A.J. , Huyghe, Jeroen R. , Newton, Christina C. , Obón‐Santacana, Mireia , Schmit, Stephanie L. , Steinfelder, Robert S. , Zaidi, Syed Hassan Ejaz , Peters, Ulrike , Phipps, Amanda I. , Cao, Yin , Chan, Andrew T , Dimou, Niki , Drew, David A , Georgeson, Peter , Giannakis, Marios , Gruber, Stephen B , Gunter, Marc J , Harrison, Tabitha A , Hoffmeister, Michael , Hsu, Li , Huang, Wen-Yi , Hullar, Meredith A , Huyghe, Jeroen R , Lynch, Brigid M , Moreno, Victor , Newton, Christina C , Nowak, Jonathan A , Obón-Santacana, Mireia , Ogino, Shuji , Qu, Conghui , Schmit, Stephanie L , Steinfelder, Robert S , Sun, Wei , Thomas, Claire E , Toland, Amanda Ewart , Trinh, Quang M , Ugai, Tomotaka , Um, Caroline Y , Van Guelpen, Bethany , Zaidi, Syed H , Murphy, Neil , Peters, Ulrike , Phipps, Amanda I , Tsilidis, Konstantinos K , Buchanan, Daniel D , Campbell, Peter T , Aglago, Elom K , Markozannes, Georgios , Cao, Yin , Gunter, Marc J. , Hoffmeister, Michael , Huang, Wen‐Yi , Moreno, Vı́ctor , Nowak, Jonathan A. , Qu, Conghui , Sun, Wei , Thomas, Claire E. , Trinh, Quang M. , Um, Caroline Y. , Guelpen, Bethany Van , Murphy, Neil , Tsilidis, Konstantinos K.

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | February 3, 2025 | Volume: 34 | Issue: 4 | Pages: 568-577

10.1158/1055-9965.epi-24-1534 | PMID 39898780 Get It

Abstract Background: Waist circumference (WC) and its allometric counterpart, “a body shape index” (ABSI), are risk factors for colorectal cancer; however, it is uncertain whether associations with these body measurements are limited to specific molecular subtypes of the disease. Methods: Data from 2,772 colorectal cancer cases and 3,521 controls were pooled from four cohort studies within the Genetics and Epidemiology of Colorectal Cancer Consortium. Four molecular markers (BRAF mutation, KRAS mutation, CpG island methylator phenotype, and microsatellite instability) were analyzed individually and in combination (Jass types). Multivariable logistic and multinomial logistic models were used to assess the associations of WC and ABSI with overall colorectal cancer risk and, in case-only analyses, to evaluate heterogeneity by molecular subtype, respectively. Results: Higher WC (ORper 5 cm = 1.06, 95% confidence interval, 1.04–1.09) and ABSI (ORper 1-SD = 1.07, 95% confidence interval, 1.00–1.14) were associated with elevated colorectal cancer risk. There was no evidence of heterogeneity between the molecular subtypes. No difference was observed regarding the influence of WC and ABSI on the four major molecular markers in proximal colon, distal colon, and rectal cancers, as well as in early- and late-onset colorectal cancers. Associations did not differ in the Jass-type analysis. Conclusions: Higher WC and ABSI were associated with elevated colorectal cancer risk; however, they do not differentially influence all four major molecular mutations involved in colorectal carcinogenesis but underscore the importance of maintaining a healthy body weight in colorectal cancer prevention. Impact: The proposed results have potential utility in colorectal cancer prevention.